Sumitomo Pharma Co., Ltd. (OTCMKTS:DNPUF – Get Free Report) traded up 0.9% during mid-day trading on Monday . The stock traded as high as $17.4725 and last traded at $16.25. 2,832 shares changed hands during mid-day trading, an increase of 18% from the average session volume of 2,404 shares. The stock had previously closed at $16.10.
Sumitomo Pharma Stock Performance
The stock’s 50 day moving average is $14.57 and its two-hundred day moving average is $12.89.
Sumitomo Pharma Company Profile
Sumitomo Pharma Co, Ltd., trading OTC under the ticker DNPUF, is a global pharmaceutical company headquartered in Osaka, Japan. It engages in the research, development, manufacturing and marketing of prescription medicines. As part of the broader Sumitomo Group, the company applies integrated drug discovery platforms and collaborative partnerships to bring innovative therapies to market.
The company’s portfolio encompasses central nervous system disorders, oncology, immunology and regenerative medicine.
See Also
- Five stocks we like better than Sumitomo Pharma
- Elon Musk already made me a “wealthy man”
- Unlocked: Elon Musk’s Next Big IPO
- Elon’s Secret AI Partner?
- Buffett, Gates and Bezos Quietly Dumping Stocks—Here’s Why
- ~$1.5T SpaceX IPO: Pre-IPO Opportunity
Receive News & Ratings for Sumitomo Pharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sumitomo Pharma and related companies with MarketBeat.com's FREE daily email newsletter.
